In addition, MEG3 promotes NSCLC cell proliferation by aberrant downregulation, the levels of which are correlated with the course of lung cancer, tumor size, and prognostic status (33) and strengthen the sensitivity of lung cancer cells to chemotherapeutic agents (34). Here, MEG3 is linked to lung carcinoma.